Loading clinical trials...
Loading clinical trials...
Effect of Transcutaneous Electrical Acupoint Stimulation on Postoperative Complications After Cranial Endovascular Treatment
In this prospective randomized controlled trial, the subjects will be assigned to group transcutaneous electrical acupoint stimulation (TEAS) and group control (no intervention). The postoperative outcomes including NIHSS (National Institute of Health stroke scale) score, morbidity and mortality will be evaluated during hospital stay and by one year after surgery.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Xijing hospital, Fourth military medical university
Xi'an, Shaanxi, China
Start Date
July 26, 2022
Primary Completion Date
June 30, 2023
Completion Date
June 30, 2023
Last Updated
December 6, 2022
158
ESTIMATED participants
transcutaneous electrical acupoint stimulation
DEVICE
Lead Sponsor
Zhihong LU
NCT06972966
NCT06766422
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07438275